SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,094.64 166.49
( 0.21%)

Global Indices

Nasdaq

52,497.89 268.83
(0.51%)

Dow Jones

7,510.69 52.06
(0.70%)

Hang Seng

64,316.33 2,448.90
(3.96%)

Nikkei 225

10,879.26 -18.01
(-0.17%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Parmax Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

540359

INE240T01014

-18.3323978

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

39.2

EPS(TTM)

Face Value()

Div & Yield %

Back

simplex papers ltd

3B Blackbio DX consolidated net profit rises 62.16% in the December 2025 quarter

Feb 06,2026

Net profit of 3B Blackbio DX rose 62.16% to Rs 21.73 crore in the quarter ended December 2025 as against Rs 13.40 crore during the previous quarter ended December 2024. Sales rose 98.31% to Rs 50.35 crore in the quarter ended December 2025 as against Rs 25.39 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	50.35	25.39	98
OPM %	43.12	59.39	-
PBDT	27.22	18.06	51
PBT	26.84	17.80	51
NP	21.73	13.40	62

78,094.64 166.49 ( 0.21%)

52,497.89 268.83 (0.51%)

7,510.69 52.06 (0.70%)

64,316.33 2,448.90 (3.96%)

10,879.26 -18.01 (-0.17%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)